Moneycontrol PRO
LAMF
LAMF

Bafna Pharmaceuticals

Jump to
  • Bafna Pharma Standalone September 2025 Net Sales at Rs 35.47 crore, down 12.04% Y-o-Y

  • Bafna Pharma Standalone March 2025 Net Sales at Rs 39.06 crore, down 5.65% Y-o-Y

  • Bafna Pharma Standalone December 2024 Net Sales at Rs 33.19 crore, up 16.68% Y-o-Y

  • Bafna Pharma Standalone September 2024 Net Sales at Rs 40.32 crore, down 0.87% Y-o-Y

  • Bafna Pharma Standalone June 2024 Net Sales at Rs 33.29 crore, down 20.65% Y-o-Y

  • Bafna Pharma Standalone March 2024 Net Sales at Rs 41.40 crore, down 2% Y-o-Y

  • Bafna Pharma Standalone December 2023 Net Sales at Rs 28.44 crore, down 16.88% Y-o-Y

  • Bafna Pharma Standalone September 2023 Net Sales at Rs 40.68 crore, up 85.23% Y-o-Y

  • Bafna Pharma Standalone June 2023 Net Sales at Rs 41.95 crore, up 147.81% Y-o-Y

  • Bafna Pharma Standalone March 2023 Net Sales at Rs 42.24 crore, up 181.96% Y-o-Y

  • Bafna Pharma Standalone December 2022 Net Sales at Rs 34.22 crore, up 67.25% Y-o-Y

  • Bafna Pharma Standalone June 2022 Net Sales at Rs 16.93 crore, down 20.38% Y-o-Y

  • Bafna Pharma Standalone March 2022 Net Sales at Rs 14.98 crore, down 31.4% Y-o-Y

  • Bafna Pharma Standalone December 2021 Net Sales at Rs 20.46 crore, up 17.08% Y-o-Y

  • In talks with multinational pharma cos for acquisition of brands: Bafna Pharmaceuticals

  • Bafna Pharma Standalone June 2021 Net Sales at Rs 21.26 crore, up 27.28% Y-o-Y

  • Bafna Pharma Standalone December 2020 Net Sales at Rs 17.48 crore, up 59.95% Y-o-Y

  • Bafna Pharma Standalone March 2020 Net Sales at Rs 13.13 crore, up 38.32% Y-o-Y

  • Bafna Pharma Standalone June 2019 Net Sales at Rs 6.85 crore, down 42.69% Y-o-Y

  • Bafna Pharma Standalone December 2018 Net Sales at Rs 13.07 crore, up 20.37% Y-o-Y

  • Stocks in news: Aurobindo, NALCO, Dabur, Manaksia, BEML, Sobha

  • Stocks in news: Tata Steel, BPCL, Bajaj Auto, Tata Elxsi

  • Stocks in news: ITC, Maruti, Eicher, MOIL, Mukand, Hathway Cable

  • Stocks in news: Torrent Power, GAIL, IOC, Eros, Aptech, Subros

  • Top buzzing midcap stocks to trade on June 10

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347